Christopher Robinson/LinkedIn
May 20, 2026, 07:27
Christopher Robinson: SNRI vs SSRI and the Risk of Hypertensive Disorders of Pregnancy
Christopher Robinson, Associate Professor Maternal Fetal Medicine at University of South Carolina, shared a post on LinkedIn:
“AJOG Presents: Serotonin-norepinephrine reuptake inhibitors vs selective serotonin reuptake inhibitors and the risk of hypertensive disorders of pregnancy.”
Title: Serotonin-norepinephrine reuptake inhibitors vs selective serotonin reuptake inhibitors and the risk of hypertensive disorders of pregnancy
Authors: Anick Bérard, Yves Mufike Lumu, Odile Sheehy, Gabra Nohmie, Narimene Ait Belkacem
Proceed to the video attached to the post.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Sep 13, 2026, 15:11Sachintha Alwis: From Impaired Sperm Motility to Microrobotics
-
Sep 13, 2026, 15:08Laurence Orbuch: Before Endometriosis Surgery, Ask…
-
Sep 13, 2026, 15:05Ademola Ayodele: IUI, IVF or Egg Freezing – Which One Is Right for You?
-
Sep 13, 2026, 14:59Fiona Pathiraja-Møller: Tennis Players No Longer Have to Choose Between Career and Family
-
Sep 13, 2026, 14:571-Day Virtual Experience for People Impacted by PMOS – PCOS Awareness Association
-
Sep 13, 2026, 14:53Ozor Victor: Behind Every Embryo Is a Story of Science, Precision, and Hope
-
Sep 13, 2026, 14:50Diana Kayal: What They Don’t Tell You About IVF
-
Sep 13, 2026, 14:44Vikram Sinai Talaulikar: A Heartfelt Thank You to All Who Donated and Supported “Menopause and Cancer”
-
Sep 13, 2026, 14:41Nicole McPherson: Changing IVF Practices Is Hard – Integration Needs to Be Easy